Skip to main content Accessibility help
×
Home
  • Print publication year: 2009
  • Online publication date: August 2010

18 - Sleep in Parkinson’s disease

from Part 3 - Sleepdisorders in the elderly

Related content

Powered by UNSILO

References

1. FruchtS, RogersJD, GreenePE, GordonMF, FahnS. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 1999;52(9):1908–10.
2. PostumaRB, MontplaisirJ. Potential early markers of Parkinson’s disease in idiopathic rapid-eye-movement sleep behaviour disorder. Lancet Neurol 2006;5(7):552–3.
3. FronczekR, OvereemS, LeeSY, et al. Hypocretin (orexin) loss in Parkinson’s disease. Brain 2007;130(Pt 6):1577–85.
4. TandbergE, LarsenJP, KarlsenK. A community-based study of sleep disorders in patients with Parkinson’s disease. Mov Disord 1998;13(6):895–9.
5. FactorSA, McAlarneyT, Sanchez-RamosJR, WeinerWJ. Sleep disorders and sleep effect in Parkinson’s disease. Mov Disord 1990;5(4):280–5.
6. LeesAJ, BlackburnNA, CampbellVL. The nighttime problems of Parkinson’s disease. Clin Neuropharmacol 1988;11(6):512–19.
7. DhawanV, DhoatS, WilliamsAJ, et al. The range and nature of sleep dysfunction in untreated Parkinson’s disease (PD): a comparative controlled clinical study using the Parkinson’s disease sleep scale and selective polysomnography. J Neurological Sci 2006;248(1–2):158–62.
8. ComellaCL. Sleep disturbances in Parkinson’s disease. Curr Neurol Neurosci Rep 2003;3(2):173–80.
9. GjerstadMD, Wentzel-LarsenT, AarslandD, LarsenJP. Insomnia in Parkinson’s disease: frequency and progression over time. J Neurol Neurosurg Psychiatry 2007;78(5):476–9.
10. AskenasyJJ, YahrMD. Parkinsonian tremor loses its alternating aspect during non-REM sleep and is inhibited by REM sleep. J Neurol Neurosurg Psychiatry 1990;53(9):749–53.
11. AskenasyJJ. Sleep in Parkinson’s disease. Acta Neurologica Scandinavica 1993;87(3):167–70.
12. LinazasoroG, Marti MassoJF, SuarezJA. Nocturnal akathisia in Parkinson’s disease: treatment with clozapine. Mov Disord 1993;8(2):171–4.
13. van HiltenB, HoffJI, MiddelkoopHA, et al. Sleep disruption in Parkinson’s disease: assessment by continuous activity monitoring. Arch Neurol 1994;51(9):922–8.
14. StackEL, AshburnAM. Impaired bed mobility and disordered sleep in Parkinson’s disease. Mov Disord 2006;21(9):1340–2.
15. LeesAJ. A sustained-release formulation of L-dopa (Madopar HBS) in the treatment of nocturnal and early-morning disabilities in Parkinson’s disease. Eur Neurol 1987;27(Suppl. 1):126–34.
16. PrianoL, AlbaniG, BrioschiA, et al. Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment. Neurol Sci 2003;24(3):207–8.
17. RomigiA, StanzioneP, MarcianiMG, et al. Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson’s disease: an open label 24-hour polysomnographic study. J Neural Transm 2006;113(12):1909–13.
18. ComellaCL, MorrisseyM, JankoK. Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy. Neurology 2005;64(8):1450–1.
19. NausiedaPA, GlantzR, WeberS, BaumR, KlawansHL. Psychiatric complications of levodopa therapy of Parkinson’s disease. Adv Neurol 1984;40:271–7.
20. GrandasF, IranzoA. Nocturnal problems occurring in Parkinson’s disease. Neurology 2004;63(8 Suppl. 3):S8–11.
21. Gomez-EstebanJC, ZarranzJJ, LezcanoE, et al. Sleep complaints and their relation with drug treatment in patients suffering from Parkinson’s disease. Mov Disord 2006;21(7):983–8.
22. SchenckCH, BundlieSR, EttingerMG, MahowaldMW. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 2002;25(2):293–308.
23. SchenckCH, HurwitzTD, MahowaldMW. REM sleep behavior disorder. Am J Psychiatry 1988;145(5):652.
24. BoeveBF, SilberMH, ParisiJE, et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 2003;61(1):40–5.
25. GagnonJF, PostumaRB, MazzaS, DoyonJ, MontplaisirJ. Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases. Lancet Neurol 2006;5(5):424–32.
26. IranzoA, SchenckCH, FonteJ. REM sleep behavior disorder and other sleep disturbances in Disney animated films. Sleep Med 2007;8(5):531–6.
27. PlazziG, CorsiniR, ProviniF, et al. REM sleep behavior disorders in multiple system atrophy. Neurology 1997;48(4):1094–7.
28. VetrugnoR, ProviniF, CortelliP, et al. Sleep disorders in multiple system atrophy: a correlative video-polysomnographic study. Sleep Med 2004;5(1):21–30.
29. ComellaCL, NardineTM, DiederichNJ, StebbinsGT. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson’s disease. Neurology 1998;51(2):526–9.
30. GagnonJF, BedardMA, FantiniML, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease. Neurology 2002;59(4):585–9.
31. ScaglioneC, VignatelliL, PlazziG, et al. REM sleep behaviour disorder in Parkinson’s disease: a questionnaire-based study. Neurol Sci 2005;25(6):316–21.
32. OzekmekciS, ApaydinH, KilicE. Clinical features of 35 patients with Parkinson’s disease displaying REM behavior disorder. Clin Neurol Neurosurg 2005;107(4):306–9.
33. SchenckCH, BundlieSR, MahowaldMW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 1996;46(2):388–93.
34. OlsonEJ, BoeveBF, SilberMH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 2000;123(Pt 2):331–9.
35. IranzoA, MolinuevoJL, SantamariaJ, et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 2006;5(7):572–7.
36. Fantini, ML, Ferini-StrambiL, MontplaisirJ. Idiopathic REM sleep behavior disorder: toward a better nosologic definition. Neurology 2005;64(5):780–6.
37. BoeveBF, SilberMH, SaperCB, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007;130:2770–88.
38. BraakH, Del TrediciK, RubU, et al. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 2003;24(2):197–211.
39. EisensehrI, LinkeR, NoachtarS, et al. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder: comparison with Parkinson’s disease and controls. Brain 2000;123(Pt 6):1155–60.
40. EisensehrI, LinkeR, TatschK, et al. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters: IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson’s disease, and controls. Sleep 2003;26(5):507–12.
41. De CockVC, VidailhetM, LeuS, et al. Restoration of normal motor control in Parkinson’s disease during REM sleep. Brain 2007;130(Pt 2):450–6.
42. BoeveBF, SaperCB. REM sleep behavior disorder: a possible early marker for synucleinopathies. Neurology 2006;66(6):796–7.
43. PacchettiC, ManniR, ZangagliaR, et al. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson’s disease. Mov Disord 2005;20(11):1439–48.
44. ArnulfI, BonnetAM, DamierP, et al. Hallucinations, REM sleep, and Parkinson’s disease: a medical hypothesis. Neurology 2000;55(2):281–8.
45. SinforianiE, ZangagliaR, ManniR, et al. REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson’s disease. Mov Disord 2006;21(4):462–6.
46. SchenckCH, MahowaldMW. Rapid eye movement sleep parasomnias. Neurol Clin 2005;23(4):1107–26.
47. FantiniML, GagnonJF, FilipiniD, MontplaisirJ. The effects of pramipexole in REM sleep behavior disorder. Neurology 2003;61(10):1418–20.
48. RingmanJM, SimmonsJH. Treatment of REM sleep behavior disorder with donepezil: a report of three cases. Neurology 2000;55(6):870–1.
49. BoeveBF, SilberMH, FermanTJ. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med 2003;4(4):281–4.
50. StriederDJ, BakerWG, BaringerJR, KazemiH. Chronic hypoventilation of central origin: a case with encephalitis lethargica and Parkinson’s syndrome. Am Rev Resp Dis 1967;96(3):501–7.
51. WetterTC, Collado-SeidelV, PollmacherT, YassouridisA, TrenkwalderC. Sleep and periodic leg movement patterns in drug-free patients with Parkinson’s disease and multiple system atrophy. Sleep 2000;23(3):361–7.
52. ArnulfI, KonofalE, Merino-AndreuM, et al. Parkinson’s disease and sleepiness: an integral part of PD. Neurology 2002;58(7):1019–24.
53. DiederichNJ, VaillantM, LeischenM, et al. Sleep apnea syndrome in Parkinson’s disease: a case-control study in 49 patients. Mov Disord 2005;20(11):1413–8.
54. YoungA, HomeM, ChurchwardT, et al. Comparison of sleep disturbance in mild versus severe Parkinson’s disease. Sleep 2002;25(5):573–7.
55. MariaB, SophiaS, MichalisM, et al. Sleep breathing disorders in patients with idiopathic Parkinson’s disease. Respir Med 2003;97(10):1151–7.
56. FabbriniG, BarbantiP, AuriliaC, et al. Excessive daytime sleepiness in de novo and treated Parkinson’s disease. Mov Disord 2002;17(5):1026–30.
57. RyeDB. Excessive daytime sleepiness and unintended sleep in Parkinson’s disease. Curr Neurol Neurosci Rep 2006;6(2):169–76.
58. ChaudhuriKR. The basis for day and night-time control of symptoms of Parkinson’s disease. Eur J Neurol 2002;9(Suppl 3):40–3.
59. PoeweW, HoglB. Akathisia, restless legs and periodic limb movements in sleep in Parkinson’s disease. Neurology 2004;63(8 Suppl. 3):S12–16.
60. OndoWG, HeY, RajasekaranS, LeWD. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome. Mov Disord 2000;15(1):154–8.
61. PittockSJ, ParrettT, AdlerCH, et al. Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology. Mov Disord 2000;19(6):695–9.
62. WetterTC, EisensehrI, TrenkwalderC. Functional neuroimaging studies in restless legs syndrome. Sleep Med 2000;5(4):401–6.
63. LinkeR, EisensehrI, WetterTC, et al. Presynaptic dopaminergic function in patients with restless legs syndrome: are there common features with early Parkinson’s disease?Mov Disord 2004;19(10):1158–62.
64. NomuraT, InoueY, MiyakeM, et al. Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson’s disease. Mov Disord 2006;21(3):380–4.
65. Braga-NetoP, da Silva-JuniorFP, Sueli MonteF, de BruinPF, de BruinVM. Snoring and excessive daytime sleepiness in Parkinson’s disease. J Neurol Sci 2004;217(1):41–5.
66. Driver-DunckleyE, EvidenteVG, AdlerCH, et al. Restless legs syndrome in Parkinson’s disease patients may improve with subthalamic stimulation. Mov Disord 2006;21(8);1287–9.
67. KediaS, MoroE, TagliatiM, LangAE, KumarR. Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease. Neurology 2004;63(12):2410–2.
68. BordetR, DevosD, BriqueS, et al. Study of circadian melatonin secretion pattern at different stages of Parkinson’s disease. Clin Neuropharmacol 2003;26(2):65–72.
69. FertlE, AuffE, DoppelbauerA, WaldhauserF. Circadian secretion pattern of melatonin in Parkinson’s disease. J Neural Transm Park Dis Dement Sect 1991;3(1):41–7.
70. FertlE, AuffE, DoppelbauerA, WaldhauserFCircadian secretion pattern of melatonin in de novo parkinsonian patients: evidence for phase-shifting properties of l-dopa. J Neural Transm Park Dis Dement Sect 1993;5(3):227–34.
71. PausS, Schmitz-HubschT, WullnerU, et al. Bright light therapy in Parkinson’s disease: a pilot study. Mov Disord 2007;22(10):1495–8.
72. WillisGL, TurnerEJ. Primary and secondary features of Parkinson’s disease improve with strategic exposure to bright light: a case series study. Chronobiol Int 2007;24(3):521–37.
73. ShpirerI, MiniovitzA, KleinC, et al. Excessive daytime sleepiness in patients with Parkinson’s disease: a polysomnography study. Mov Disord 2006;21(9):1432–8.
74. TandbergE, LarsenJP, KarlsenK. Excessive daytime sleepiness and sleep benefit in Parkinson’s disease: a community-based study. Mov Disord 1999;14(6):922–7.
75. OndoWG, Dat VuongK, KhanH, et al. Daytime sleepiness and other sleep disorders in Parkinson’s disease. Neurology 2001;57(8):1392–6.
76. PalS, BhattacharyaKF, AgapitoC, ChaudhuriKR. A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson’s disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy. J Neural Transm 2001;108(1):71–7.
77. BarbarSI, EnrightPL, BoyleP, et al. Sleep disturbances and their correlates in elderly Japanese American men residing in Hawaii. The Journals of Gerontology 2000;55(7):M406–11.
78. FurumotoH. Excessive daytime somnolence in Japanese patients with Parkinson’s disease. Eur J Neurol 2004;11(8):535–40.
79. PausS, BrechtHM, KosterJ, et al. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson’s disease. Mov Disord 2003;18(6):659–67.
80. KornerY, MeindorfnerC, MollerJC, et al. Predictors of sudden onset of sleep in Parkinson’s disease. Mov Disord 2004;19(11):1298–305.
81. HobsonDE, LangAE, MartinWR, et al. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 2002;287(4):455–63.
82. MeindorfnerC, KornerY, MollerJC, et al. Driving in Parkinson’s disease: mobility, accidents, and sudden onset of sleep at the wheel. Mov Disord 2005;20(7):832–42.
83. AbbottA. Neuroscience: the molecular wake-up call. Nature 2007;447(7143):368–70.
84. RyeDB, BliwiseDL, DiheniaB, GureckiP. FastTRACK: daytime sleepiness in Parkinson’s disease. J Sleep Res 2000;9(1):63–9.
85. KumarS, BhatiaM, BehariM. Excessive daytime sleepiness in Parkinson’s disease as assessed by Epworth Sleepiness Scale (ESS). Sleep Med 2003;4(4):339–42.
86. LuJ, ShermanD, DevorM, SaperCB. A putative flip-flop switch for control of REM sleep. Nature 2006;441(7093):589–94.
87. DrouotX, MoutereauS, NguyenJP, et al. Low levels of ventricular CSF orexin/hypocretin in advanced PD. Neurology 2003;61(4):540–3.
88. OvereemS, van HiltenJJ, RipleyB, et al. Normal hypocretin-1 levels in Parkinson’s disease patients with excessive daytime sleepiness. Neurology 2002;58(3):498–9.
89. FrauscherB, HoglB, MaretS, et al. Association of daytime sleepiness with COMT polymorphism in patients with parkinson disease: a pilot study. Sleep 2004;27(4):733–6.
90. RisslingI, KornerY, GellerF, et al. Preprohypocretin polymorphisms in Parkinson disease patients reporting “sleep attacks”. Sleep 2005;28(7):871–5.
91. FabbriniG, BarbantiP, AuriliaC, et al. Excessive daytime somnolence in Parkinson’s disease: follow-up after 1 year of treatment. Neurol Sci 2003;24(3):178–9.
92. Parkinson Study Group. Pramipexole vs levodopa as initial treatment for Parkinson disease: a randomized controlled trial. Jama 2000;284(15):1931–8.
93. RascolO, BrooksDJ, KorczynAD, et al. A five-year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa – 056 Study Group. New Engl J Med 2000;342(20):1484–91.
94. LesserRP, FahnS, SniderSR, et al. Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy. Neurology 1979;29(9 Pt 1):1253–60.
95. SchlesingerI, RavinPD. Dopamine agonists induce episodes of irresistible daytime sleepiness. Eur Neurol 2003;49(1):30–3.
96. GhorayebI, LoundouA, AuquierP, et al. A nationwide survey of excessive daytime sleepiness in Parkinson’s disease in France. Mov Disord 2007;22(11):1567–72.
97. OndoWG, VuongKD, JankovicJ. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 2002;59(3):421–4.
98. OlanowCW, SchapiraAH, RothT. Waking up to sleep episodes in Parkinson’s disease. Mov Disord 2000;15(2):212–5.
99. BrodskyMA, GodboldJ, RothT, OlanowCW. Sleepiness in Parkinson’s disease: a controlled study. Mov Disord 2003;18(6):668–72.
100. ChaudhuriKR, PalS, DiMarcoA, et al. The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2002;73(6):629–35.
101. MarinusJ, VisserM, van HiltenJJ, LammersGJ, StiggelboutAM. Assessment of sleep and sleepiness in Parkinson disease. Sleep 2003;26(8):1049–54.
102. AdlerCH, CavinessJN, HentzJG, LindM, TiedeJ. Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson’s disease. Mov Disord 2003;18(3):87–293.
103. HoglB, SaletuM, BrandauerE, et al. Modafinil for the treatment of daytime sleepiness in Parkinson’s disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep 2002;25(8):905–9.
104. OndoWG, FayleR, AtassiF, JankovicJ. Modafinil for daytime somnolence in Parkinson’s disease: double blind, placebo controlled parallel trial. J Neurol Neurosurg Psychiatry 2005;76(12):1636–9.
105. NievesAV, LangAE. Treatment of excessive daytime sleepiness in patients with Parkinson’s disease with modafinil. Clin Neuropharmacol 2002;25(2):111–4.
106. DowlingGA, MastickJ, CollingE, et al. Melatonin for sleep disturbances in Parkinson’s disease. Sleep Med 2005;6(5):459–66.
107. AntoniniA, LandiA, MarianiC, DeNotarisR, PezzoliG. Deep brain stimulation and its effect on sleep in Parkinson’s disease. Sleep Med 2004;5(2):211–4.
108. HjortN, OstergaardK, DupontE. Improvement of sleep quality in patients with advanced Parkinson’s disease treated with deep brain stimulation of the subthalamic nucleus. Mov Disord 2004;19(2):196–9.
109. PacchettiC, ManniR, ZangagliaR, et al. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson’s disease. Mov Disord 2005;20(11):1439–48.
110. KumruH, SantamariaJ, TolosaE, et al. Rapid eye movement sleep behavior disorder in parkinsonism with parkin mutations. Annals of Neurology 2004;56(4):599–603.
111. DiederichNJ, VaillantM, LeischenM, et al. Sleep apnea syndrome in Parkinson’s disease. A case-control study in 49 patients. Mov Disord 2005;20(11):1413–18.
112. Ferini-StrambiL, FranceschiM, PintoP, ZucconiM, SmirneS. Respiration and heart rate variability during sleep in untreated Parkinson patients. Gerontology 1992;38(1-2):92–8.
113. EfthimiouJ, EllisSJ, HardieRJ, SternGM. Sleep apnea in idiopathic and postencephalitic parkinsonism. Advances in Neurology 1987;45:275–6.
114. AppsMC, SheaffPC, IngramDA, KennardC, EmpeyDW. Respiration and sleep in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1985;48(12):1240–5.
115. Gomez-EstebanJC, ZarranzJJ, TijeroB, et al. Restless legs syndrome in Parkinson’s disease. Mov Disord 2007.
116. KrishnanPR, BhatiaM, BehariM. Restless legs syndrome in Parkinson’s disease: a case-controlled study. Mov Disord 2003;18(2):181–5.
117. KumarS, BhatiaM, BehariM. Sleep disorders in Parkinson’s disease. Mov Disord 2002;17(4):775–81.
118. TanEK, LumSY, WongMC. Restless legs syndrome in Parkinson’s disease. Journal of the Neurological Sciences 2002;196(1-2):33–6.
119. LangAE. Restless legs syndrome and Parkinson’s disease: insights into pathophysiology. Clinical Neuropharmacology 1987;10(5):476–8.
120. MonacaC, DuhamelA, JacquessonJM, et al. Vigilance troubles in Parkinson’s disease: a subjective and objective polysomnographic study. Sleep Medicine 2006;7(5):448–53.
121. GjerstadMD, AlvesG, Wentzel-LarsenT, AarslandD, LarsenJP. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?Neurology 2006;67(5):853–8.
122. FerreiraJJ, DesboeufK, GalitzkyM, et al. Sleep disruption, daytime somnolence and ‘sleep attacks’ in Parkinson’s disease: a clinical survey in PD patients and age-matched healthy volunteers. Eur J Neurol 2006;13(3):209–14.
123. WegelinJ, McNamaraP, DursoR, BrownA, McLarenD. Correlates of excessive daytime sleepiness in Parkinson’s disease. Parkinsonism Relat Disord 2005;11(7):441–8.
124. ManniR, TerzaghiM, SartoriI, ManciniF, PacchettiC. Dopamine agonists and sleepiness in PD: review of the literature and personal findings. Sleep Medicine 2004;5(2):189–93.
125. RazmyA, LangAE, ShapiroCM. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Archives of Neurology 2004;61(1):97–102.
126. HoglB, SeppiK, BrandauerE, et al. Increased daytime sleepiness in Parkinson’s disease: a questionnaire survey. Mov Disord 2003;18(3):319–23.
127. FabbriniG, BarbantiP, AuriliaC, et al. Excessive daytime somnolence in Parkinson’s disease. Follow-up after 1 year of treatment. Neurol Sci 2003;24(3):178–9.
128. Merino-AndreuM, ArnulfI, KonofalE, DerenneJP, AgidY. Unawareness of naps in Parkinson’s disease and in disorders with excessive daytime sleepiness. Neurology 2003;60(9):1553–4.
129. FabbriniG, BarbantiP, AuriliaC, et al. Excessive daytime sleepiness in de novo and treated Parkinson’s disease. Mov Disord 2002;17(5):1026–30.
130. O’SuilleabhainPE, DeweyRB, Jr. Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease. Archives of Neurology 2002;59(6):986–9.
131. TanEK, LumSY, Fook-ChongSM, et al. Evaluation of somnolence in Parkinson’s disease: comparison with age- and sex-matched controls. Neurology 2002;58(3):465–8.
132. MontastrucJL, Brefel-CourbonC, SenardJM, et al. Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study. Clinical Neuropharmacology 2001;24(3):181–3.